The cardinal role of DCs in the development of the antitumor immune response is their unique ability to engulf dying tumor cells, a principal source of tumor-associated antigens (TAAs), and cross-present TAAs to CD8+ T cells in the LNs [44]. The gene discussed is CD8A; the disease is neoplasm.